After completing this activity, participants should be better able to: Evaluate clinical trial data on the efficacy and safety of current and emerging treatments for CLL in the relapsed/refractory setting Develop individualized treatment plans for patients with CLL based on the latest clinical evidence, guideline recommendations, and patient characteristics Integrate a multidisciplinary approach to improve treatment adherence, adverse event management, and coordinated care for patients with CLL in rural and underserved settings
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 35 Nutmeg Drive
Pricing
100% of listed courses are free
20 of 20 courses listed here are free.
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.



